Skip to main content

Table 1 Baseline characteristics

From: Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent

 

BVS (n = 26)

EES (n = 34)

P-value

Age, years

54.0 ± 11.2

61.7 ± 11.4

0.012

Male, n (%)

19 (73)

30 (88)

0.122

Diabetes

   

No, n (%)

18 (69)

25 (74)

 

NIDDM, n (%)

5 (19)

9 (26)

0.117

IDDM, n (%)

3 (12)

0

 

Hypertension, n (%)

15 (58)

25 (74)

0.156

Hyperlipidemia, n (%)

17 (65)

21 (62)

0.494

Positive family history, n (%)

6 (23)

10 (29)

0.402

Smoking

   

No, n (%)

15 (58)

9 (26)

 

Ex, n (%)

2 (8)

13 (38)

0.011

Current, n (%)

9 (34)

12 (36)

 

Indication for PCI

   

ACS - STEMI, n (%)

3 (12)

1 (3)

 

ACS - NSTEMI, n (%)

7 (27)

6 (18)

0.237

Non-ACS elective, n (%)

16 (61)

27 (79)

 

LAD, n (%)

19 (73)

19 (56)

 

CX, n (%)

3 (11)

9 (26)

0.261

RCA, n (%)

4 (15)

5 (15)

 

Ramus intermedius, n (%)

1 (5)

0

 

Lesion classification

   

Type B1, n (%)

16 (62)

24 (70)

 

Type B2, n (%)

5 (19)

5 (15)

0.407

Type C, n (%)

5 (19)

5 (15)

 
  1. ACS Acute Coronary Syndrome, IDDM Insulin Dependent Diabetes Mellitus, NIDDM Non-Insulin Dependent Diabetes Mellitus, NSTEMI Non-ST Elevation Myocardial Infarction, STEMI ST Elevation Myocardial Infarction